Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Abrocitinib, baricitinib, upadacitinib and dupilumab for treating atopic dermatitis
Drug guidance

Abrocitinib, baricitinib, upadacitinib and dupilumab for treating atopic dermatitis

Skin

2 January 2024

Guidance Recommendations

Funding status

Back to top